Abstract
BackgroundThe pre-symptomatic stage of Rheumatoid arthritis (RA) is associated with pro-inflammatory cytokines and autoantibodies. High levels and epitope spread by Rheumatoid factors (RhF) and autoantibodies to citrullinated proteins signify progression towards disease expression. In established RA, the persistence of high autoantibody levels reflects production by both long-lived plasma cells and short-lived plasmablasts. Neither the relative contributions to pathogenesis by autoantibodies from either source, nor the factors responsible for deciding the fate of autoantigen specific ‘parent’ B-cells, is understood. Phenotypic markers identifying subsets of autoreactive B-cells are therefore of interest in understanding the origin and perpetuation of the autoimmune response in RA. One such phenotypic marker is the rat monoclonal antibody, 9G4, which recognises an idiotope on immunoglobuins derived from the inherently autoreactive VH-gene, VH4-34. We therefore investigated whether the 9G4 idiotope was expressed on autoantibodies in patients with RA.Methodology/Principal FindingsSera from 19 patients with established RA and those with <1year history of untreated polyarthritis either resolving into RA (n = 42) or non-RA diagnosis (n = 31) were included. Autoantibodies to cyclic citrullinated peptides (CCP), RhF and co-expression of the 9G4 idiotope were measured by ELISA. 9G4 recognised a population of anti-CCP antibodies in the majority of sera from patients with established disease and also in samples from patients with early disaese. 9G4+RhF levels were generally lower and not associated with positivity for, or levels of 9G4+CCP.Conclusions/SignificanceThe persistence of 9G4+ immunoglobulins, of any isotype, in serum is rare. We describe here the novel finding of 9G4 expression on anti-CCP antibodies in patients from the earliest symptoms of RA through to established disease. Our results suggest that 9G4 expression on anti-CCP autoantibodies was not due to polyclonal expansion of VH4-34-encoded immunoglobulins. These studies may therefore provide a new focus for investigation into the evolution of the autoimmune response in RA patients.
Highlights
The serology of patients with Rheumatoid arthritis (RA) is characterised by persistently raised levels of autoantibodies of two main specificities, being those against Fc of IgG (Rheumatoid factors, RhF) and to peptide sequences on a number of different proteins which have undergone citrullination [1,2,3]
VH4-34 gene usage has been shown to be obligatory for the production of most pathogenic IgM cold-agglutinins and has been for demonstrated in IgM-RhF, IgG anti-dsDNA antibodies in systemic lupus erythematosus (SLE), and IgM anti-myeloperoxidase antibodies in systemic vasculitis [24,25,26,27]
Patients in the Very Early Non-RA (VENRA) group were resolved into diagnostic categories of spondyloarthritis (6), SLE (5), polymyalgia rheumatica (4), microcrystalline arthritis (2), Sjogren syndrome (1), undifferentiated diffuse connective tissue disease (1), viral polyarthritis (1), arthritis associated with malignancy (1) and 5 patients entered spontaneously into remission
Summary
The serology of patients with Rheumatoid arthritis (RA) is characterised by persistently raised levels of autoantibodies of two main specificities, being those against Fc of IgG (Rheumatoid factors, RhF) and to peptide sequences on a number of different proteins which have undergone citrullination (anti-citrullinated protein/peptide antibodies - ACPA) [1,2,3]. Multiple isotypes of both RhF and ACPA and epitope spread of ACPA can precede the development of clinical disease by many months or years [4,5,6,7,8]. We investigated whether the 9G4 idiotope was expressed on autoantibodies in patients with RA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.